RecruitingNot ApplicableNCT06582693

Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network

Sponsor

Children's Hospital of Philadelphia

Enrollment

3,200 participants

Start Date

Sep 6, 2024

Study Type

INTERVENTIONAL

Conditions

Smoking Smoking Cessation Second Hand Tobacco Smoke

Summary

The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.

Eligibility

Min Age: 18 Years

Inclusion Criteria8

Males or females ages ≥18 years in age
Self-identify as a current combustible tobacco user
Have a valid cell phone number
Must be a CHOP patient
Males or females ages ≥18 years in age
Self-identify as a current combustible tobacco user
Have a valid cell phone number
Must be a CHOP patient

Exclusion Criteria6

\<18 years in age.
Indicates no combustible tobacco smoking
Not a CHOP patient
\<18 years in age.
Indicates no combustible tobacco smoking
Not a CHOP patient

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRefer2Quit

The Refer2Quit intervention consists of automatic connection to the adult participant's choice of any or all of four evidence-based tobacco treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), as well as motivational counseling provided by the study team. Supportive and motivational text messaging is also included in the intervention to connect or reconnect adult participants to treatments as needed. Text messaging and support would also focus on supporting appropriate use of NRT and/or varenicline if indicated.